Report ID: UCMIG35H2028
Report ID:
UCMIG35H2028 |
Region:
Global |
Published Date: Upcoming |
Pages:
165
| Tables: 55 | Figures: 60
A DNA vaccine is a small, circular DNA plasmid that encodes one or more protein antigens under the control of a promoter in order to elicit a specific immune response to disease. DNA vaccines are third-generation vaccines that are specifically designed to overcome the undesirable characteristics of conventional vaccines. The main driving factors of the DNA vaccines market include an increase in the prevalence of cancer and infectious diseases in humans and animals, as well as an increase in demand for DNA vaccines due to benefits such as low risk of infection, easy transportation, and room temperature stability. Furthermore, the increasing number of antibiotic-resistant pathogens has created a need for effective and low-cost vaccination, such as DNA vaccines, which would provide long-term immunity, boosting the growth of DNA vaccines market.
This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.
Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.
The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Biotechnology by segment aggregation, the contribution of the Biotechnology in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.
To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONThe market for DNA Vaccine was estimated to be valued at US$ XX Mn in 2021.
The DNA Vaccine Market is estimated to grow at a CAGR of XX% by 2028.
The DNA Vaccine Market is segmented on the basis of Product Type, Type, End User, Region.
Based on region, the DNA Vaccine Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.
The key players operating in the DNA Vaccine Market are BOEHRINGER INGELHEIM GmbH (Merial), ELI-LILLY (Novartis Animal Health), GeneOne Life Science, GEOVAX LABS, INC, Inovio Pharmaceuticals (VGX Animal Health), Genexine, Inc., VIATRIS INC. (Rottapharm Biotech), Takara Holdings (Takara Bio), ZOETIS INC. (Fort dodge Animal Health), Zydus Cadila.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: UCMIG35H2028